View in EDS

Replacing the SpCas9 HNH domain by deaminases generates compact base editors with an alternative targeting scope.

Saved in:

Bibliographic Details
Title:	Replacing the SpCas9 HNH domain by deaminases generates compact base editors with an alternative targeting scope.
Authors:	Villiger L; Department of Biology, ETH Zurich, Institute for Molecular Health Sciences, Zurich, Switzerland.; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland., Schmidheini L; Department of Biology, ETH Zurich, Institute for Molecular Health Sciences, Zurich, Switzerland.; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland., Mathis N; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland., Rothgangl T; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland., Marquart K; Department of Biology, ETH Zurich, Institute for Molecular Health Sciences, Zurich, Switzerland.; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland., Schwank G; Department of Biology, ETH Zurich, Institute for Molecular Health Sciences, Zurich, Switzerland.; University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.
Source:	Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2021 Aug 26; Vol. 26, pp. 502-510. Date of Electronic Publication: 2021 Aug 26 (Print Publication: 2021).
Publication Type:	Journal Article
Journal Info:	Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2162-2531
DOI:	10.1016/j.omtn.2021.08.025